Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Barbro Friden"'
Publikováno v:
Fertility and Sterility. 87:603-606
Objective To sequence the coding regions of the luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR) genes to find out if polymorphisms in them are responsible for the severe form of ovarian hyperstimulation syndrome (O
Publikováno v:
Fertility and Sterility. 81:258-261
Objective To investigate reasons for discontinuation of IVF treatment. Design Prospective, cohort study. Setting Center for reproductive medicine at a large university hospital. Patient(s) The 450 couples of a cohort of 974 couples who started IVF tr
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 82:654-658
Background. The aim of this study was to evaluate treatment efficacy and patient compliance in women with an early miscarriage managed expectantly in routine clinical practice. Methods. During 1995-98, 263 consecutive women who sought medical attenti
Publikováno v:
Human Reproduction. 20:2556-2558
In vitro maturation of oocytes (IVM) has been developed as a treatment option for subjects with good prognosis in assisted reproduction. We present successful IVM treatment in connection with a woman from whom low numbers of embryos were obtained aft
Publikováno v:
Fertility and sterility. 77(3)
Objective: To assess the probability of live birth after three available in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles. Design: Retrospective, observational study. Setting: University hospital. Patient(s): Nine hundred sev
Publikováno v:
Fertility and sterility. 73(2)
Objective: To test the hypothesis that paraluteal cells in the human corpus luteum (CL) modulate steroidogenesis and prostaglandin production by the CL. Design: In vitro cell culture study using human luteal cells. Setting and Patient(s): Women (n =
Publikováno v:
Getinge AB MarketLine Company Profile. 9/16/2024, p1-34. 34p.
Publikováno v:
Fertility and Sterility. 81:276
A considerable number of patients discontinue in vitro fertilization treatment because of psychological reasons.
Publikováno v:
Getinge AB MarketLine Company Profile. 12/26/2023, p1-7. 7p.
Publikováno v:
Getinge AB MarketLine Company Profile. 12/1/2022, p1-32. 32p.